What are the Challenges Faced by Novartis in Nanotechnology?
Regulatory Hurdles One of the primary challenges is navigating the complex regulatory landscape. Nanotechnology-based products must meet stringent safety and efficacy standards, which can be a time-consuming and costly process.
Manufacturing Scaling up the production of nanomaterials while maintaining consistency and quality is another significant challenge. The manufacturing processes for nanomaterials are often complex and require specialized equipment and expertise.
Public Perception The public's perception of nanotechnology is another hurdle. There are concerns about the long-term effects of nanomaterials on health and the environment. Novartis must invest in educating the public and ensuring transparency in their research and development efforts.
